Title: Phase I study of EMD 525797 (DI17E6), an antibody targeting alpha upsilon beta integrins, in combination with cetuximab and irinotecan, as a second-line treatment for patients with k-ras wild-type metastatic colorectal cancer
Authors: Elez, Elena
Kocakova, Ilona
Hoehler, Thomas
Martens, Uwe Marc
Bokemeyer, Carsten
Van Cutsem, Eric
Fram, Robert J
Bernard, Laurence
Tabernero, Josep
Issue Date: 2012
Publisher: Grune & Stratton
Host Document: Journal of Clinical Oncology vol:30 issue:15
Conference: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) location:Chicago: IL date:JUN 01-06, 2012
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Clinical Digestive Oncology (+)

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.